Atazanavir (Reyataz): Basics
- Patient Information About Reyataz (Atazanavir) (PDF) (January 2013)
From Bristol-Myers Squibb Company
- An Overview of Reyataz (Atazanavir) (September 13, 2012)
From AIDSinfo
- Atazanavir (Reyataz) (March 28, 2012)
To read PDF, click here.
From AIDS InfoNet
- Reyataz (March/April 2012)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- FAQs About Reyataz (Atazanavir) (January 25, 2012)
From The Body's "Ask the Experts" Forums
- Reyataz (Atazanavir) (September 28, 2008)
Basic information on dosing schedules and side effects.
From U.S. Department of Veterans Affairs
- Reyataz (Atazanavir) Package Insert Revisions (January 16, 2008)
From U.S. Food and Drug Administration
- Atazanavir (Reyataz) (August 15, 2006)
From AIDS Treatment Data Network
- Labeling Changes for Atazanavir (Reyataz) (January 26, 2006)
To read PDF, click here.
From U.S. Food and Drug Administration
- HIV JournalView: Putting Atazanavir + Ritonavir on the Map (July/August 2005)
A study finds the combo is comparable to lopinavir/ritonavir in patients with some baseline protease inhibitor resistance.
From TheBodyPRO.com
- Reyataz (Atazanavir) (May 2005)
To read PDF, click here.
From The Center for AIDS
- Three New Drugs Approved by FDA (November/December 2003)
An overview of Fuzeon (enfuvirtide, T-20), Reyataz (atazanavir) and Emtriva (emtricitabine, FTC).
In Survival News, from AIDS Survival Project
- The Bottom Line on T-20 (Fuzeon), Atazanavir (Reyataz) and FTC (Emtriva) (October 2003)
Bare-bones highlights of three of this year's new HIV medications.
To read PDF, click here.
In Project Inform Perspective, from Project Inform
- Access Information for T-20 (Fuzeon), Atazanavir (Reyataz) and FTC (Emtriva) (October 2003)
How to get information about receiving these new HIV medications through ADAPs and Patient Assistance Programs.
To read PDF, click here.
In Project Inform Perspective, from Project Inform
- Position Paper on Atazanavir (BMS-232623, Reyataz) (July 23, 2003)
In TAGline, from Treatment Action Group
- Two Pills Once a Day. No Cholesterol or Triglyceride Issues? You Say This Is a Protease Inhibitor? Atazanavir (Reyataz) Gains FDA Approval (Summer 2003)
In Resolute!, from PWA Coalition Colorado
- Atazanavir Briefing Document (PDF) (May 2003)
Submitted to the FDA in advance of its May 13 Antiviral Drugs Advisory Committee meeting.
From Bristol-Myers Squibb Company
- FDA Review Document: Reyataz (Atazanavir Sulfate) Capsules and Powder for Oral Use (April 14, 2003)
To read PDF, click here.
From U.S. Food and Drug Administration
|
Advertisement
|
Email
Glossary
